Concerning CTAGE5-KHDRBS3, SDK1-AMACR, and RAD50-PDLIM4 gene fusions Ren proven their occurrence also in the additional 54 prostate tumor samples analysed (with percentages ranging from 24 to 37%). This evidence concerns the gene SDK1 and prostate neoplasm.